Shih-Wei Wang L

32PUBLICATIONS
39CO-AUTHORS
Biomolecular modelling and designCardiovascular medicine and haematology not elsewhere classifiedChemotherapyPredictive and prognostic markersPhycology (incl. marine grasses)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Mar 26, 2025
Long-Term Safety Evaluation of Fluorescent Gold Nanoclusters Conjugated with α-Lipoic Acid: Insights from a Six-Month In Vivo Study.

Yu-Wei Lai, Yi-Nan Lee, Hung-I Yeh

|Nov 27, 2024
Correction: Chen et al. Heteronemin Suppresses Lymphangiogenesis Through ARF-1 and MMP-9/VE-Cadherin/Vimentin. Biomedicines 2021, 9, 1109.

Hsien-Lin Chen, Yu-Chieh Su, Huang-Chi Chen

|Jun 26, 2024
Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma.

Hsiao-Chi Tsai, Ming-Yu Lien, Shih-Wei Wang

|May 25, 2024
Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma.

Chang-Yu Song, Shang-Lin Hsieh, Shang-Yu Yang

|Nov 25, 2023
Anti-Lymphangiogenic Terpenoids from the Heartwood of Taiwan Juniper, Juniperus chinensis var. tsukusiensis.

Ho-Cheng Wu, Lung-Lin Shiu, Shih-Wei Wang

|May 01, 2023
CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents.

Cong-Min Peng, Shih-Wei Wang, Yi-Lin Hwang

Pageof 6

Frequent Collaborators

15 joint publications

Chih-Hsin Tang

5 joint publications

Chun-Hao Tsai

3 joint publications

Tzong-Huei Lee

3 joint publications

Jih-Jung Chen